Medical Articles 1/23
Posted by rob on January 23, 2007 under Uncategorized | 
Be the First to Comment
| Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia. |
document.write(_IG_FR_date()) |
 |
Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. |
document.write(_IG_FR_date()) |
|
RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation. | document.write(_IG_FR_date()) |
|
Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant. |
document.write(_IG_FR_date()) |
|
Camptothecin acts synergistically with imatinib and overcomes imatinib resistance through Bcr-Abl independence in human K562 cells. |
document.write(_IG_FR_date()) |
|
Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience. | document.write(_IG_FR_date()) |
|
[Flt-3/ITD Mutation in Pediatric Leukemia and Its Clinical Significance.] | document.write(_IG_FR_date()) |
|
[Four cases of therapy-related leukemia in multiple myeloma.] |